{"transactions":[{"id":1356,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:05:05.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":10257,"price":2.7408,"value":28112.3856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.7408, and the range of prices were between $2.70 and $2.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided"}],"balance_after":318480,"source":{"system":"sec-edgar","filing":"0001493152-26-041285","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226041285/ownership.xml","form_type":"4"}},{"id":697467,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-08-05T00:20:10.000Z","date":"2026-08-04","kind":"sale","planned":false,"acquired":false,"shares":653,"price":2.9467,"value":1924.1951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9467, and the range of prices were between $2.91 and $2.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":328737,"source":{"system":"sec-edgar","filing":"0001493152-26-036076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226036076/ownership.xml","form_type":"4"}},{"id":732351,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:20.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":174841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":329390,"source":{"system":"sec-edgar","filing":"0001493152-26-029419","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226029419/ownership.xml","form_type":"4"}},{"id":782832,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-05-13T00:30:05.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":605,"price":2.9742,"value":1799.391,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9742, and the range of prices were between $2.96 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":154549,"source":{"system":"sec-edgar","filing":"0001493152-26-022568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226022568/ownership.xml","form_type":"4"}},{"id":827464,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-26T21:00:22.000Z","date":"2026-03-24","kind":"sale","planned":false,"acquired":false,"shares":906,"price":2.42,"value":2192.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":155154,"source":{"system":"sec-edgar","filing":"0001493152-26-012971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226012971/ownership.xml","form_type":"4"}},{"id":972797,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:49:59.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":973,"price":5.3694,"value":5224.4262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":156060,"source":{"system":"sec-edgar","filing":"0001493152-25-027337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315225027337/ownership.xml","form_type":"4"}},{"id":972796,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:49:59.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":1463,"price":3.3574,"value":4911.8762,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":157033,"source":{"system":"sec-edgar","filing":"0001493152-25-027337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315225027337/ownership.xml","form_type":"4"}},{"id":972795,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:49:59.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":1270,"price":3.3267,"value":4224.909,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":158496,"source":{"system":"sec-edgar","filing":"0001493152-25-027337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315225027337/ownership.xml","form_type":"4"}},{"id":1050013,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":65000,"derivative":{"exercise_price":3.33,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050012,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050011,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":13333,"derivative":{"exercise_price":3.33,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050010,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050009,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":80000,"derivative":{"exercise_price":3.33,"expiration_date":"2027-09-12","underlying":"Common stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050008,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2027-09-12","underlying":"Common stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050007,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":16666,"derivative":{"exercise_price":3.33,"expiration_date":"2026-12-30","underlying":"Common stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050006,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2026-12-30","underlying":"Common stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1053014,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:47.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":142500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":142500,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":142500},"source":{"system":"sec-edgar","filing":"0001641172-25-025999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225025999/ownership.xml","form_type":"4"}},{"id":1053013,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-08-29T20:30:47.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":159766,"source":{"system":"sec-edgar","filing":"0001641172-25-025999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225025999/ownership.xml","form_type":"4"}},{"id":1151039,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2025-05-13T21:05:36.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":4737,"price":2.92,"value":13832.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":52266,"source":{"system":"sec-edgar","filing":"0001415889-25-012806","document":"form4-05132025_050531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588925012806/form4-05132025_050531.xml","form_type":"4"}},{"id":1169935,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2025-04-17T20:57:32.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":13350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025."}],"balance_after":57003,"source":{"system":"sec-edgar","filing":"0001415889-25-010880","document":"form4-04172025_080429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588925010880/form4-04172025_080429.xml","form_type":"4"}},{"id":1324370,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-21T01:45:42.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":39000,"derivative":{"exercise_price":2.29,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001415889-24-030004","document":"form4-12212024_011239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588924030004/form4-12212024_011239.xml","form_type":"4"}},{"id":1324369,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2024-12-21T01:45:42.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 25% of the RSUs vest on August 1, 2025, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."}],"balance_after":43653,"source":{"system":"sec-edgar","filing":"0001415889-24-030004","document":"form4-12212024_011239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588924030004/form4-12212024_011239.xml","form_type":"4"}},{"id":1326992,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2024-12-18T21:35:07.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":6300,"price":2.34,"value":14742.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":14653,"source":{"system":"sec-edgar","filing":"0001415889-24-029742","document":"form4-12182024_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588924029742/form4-12182024_041204.xml","form_type":"4"}},{"id":1458391,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2024-07-08T20:30:14.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":11557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents RSUs that are fully vested as of March 14, 2024."}],"balance_after":20953,"source":{"system":"sec-edgar","filing":"0001415889-24-019344","document":"form4-07082024_040711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588924019344/form4-07082024_040711.xml","form_type":"4"}},{"id":1458390,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2024-07-08T20:30:14.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":3661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024."}],"balance_after":9396,"source":{"system":"sec-edgar","filing":"0001415889-24-019344","document":"form4-07082024_040711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588924019344/form4-07082024_040711.xml","form_type":"4"}},{"id":1783149,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-12T20:23:09.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on September 11, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":65000,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-23-049099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000120919123049099/doc4.xml","form_type":"4"}},{"id":1799877,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2023-08-22T20:15:48.000Z","date":"2023-08-18","kind":"sale","planned":false,"acquired":false,"shares":3265,"price":23.73,"value":77478.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $23.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":5735,"source":{"system":"sec-edgar","filing":"0001209191-23-046883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000120919123046883/doc4.xml","form_type":"4"}},{"id":1908742,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2023-05-02T20:21:53.000Z","date":"2023-02-17","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of common stock upon vesting.  The RSUs will be fully vested on July 25, 2023."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-23-026483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000120919123026483/doc4.xml","form_type":"4"}}]}